Patent · US Active

Antibodies against GPR64 and uses thereof

US7807163B2 · kind B2 · utility

6Cited by
1References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 3, 2008
Grant dateOct 5, 2010
Priority date—
Expiry dateSep 23, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

GPR64 antibody compositions are provided. These antibodies may be used for diagnosis or treatment of cancer, especially ovarian cancer, Ewing's sarcoma, uterine cancer, and other GPR64 expressing tumor types.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.